These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11510437)

  • 1. Lipids in neural function: modulation of behavior by oral administration of endocannabinoids found in foods.
    Crozier Willi G; Berger A; Di Marzo V; Bisogno T; De Petrocellis L; Fride E; Mechoulam R
    Nestle Nutr Workshop Ser Clin Perform Programme; 2001; 5():169-84; discussion 185-7. PubMed ID: 11510437
    [No Abstract]   [Full Text] [Related]  

  • 2. A new endothelial target for cannabinoids.
    Randall MD
    Mol Pharmacol; 2003 Mar; 63(3):469-70. PubMed ID: 12606752
    [No Abstract]   [Full Text] [Related]  

  • 3. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase.
    Reggio PH; Traore H
    Chem Phys Lipids; 2000 Nov; 108(1-2):15-35. PubMed ID: 11106780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemistry of the endogenous ligands of cannabinoid receptors.
    Di Marzo V; Deutsch DG
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):386-404. PubMed ID: 9974173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators.
    Di Marzo V
    Life Sci; 1999; 65(6-7):645-55. PubMed ID: 10462065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology.
    Giuffrida A; Beltramo M; Piomelli D
    J Pharmacol Exp Ther; 2001 Jul; 298(1):7-14. PubMed ID: 11408519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
    van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
    J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges.
    Schmid HH; Schmid PC; Berdyshev EV
    Chem Phys Lipids; 2002 Dec; 121(1-2):111-34. PubMed ID: 12505695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol.
    Hillard CJ
    Prostaglandins Other Lipid Mediat; 2000 Apr; 61(1-2):3-18. PubMed ID: 10785538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The quest for a vascular endothelial cannabinoid receptor.
    Kunos G; Bátkai S; Offertáler L; Mo F; Liu J; Karcher J; Harvey-White J
    Chem Phys Lipids; 2002 Dec; 121(1-2):45-56. PubMed ID: 12505689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoids and the gut.
    Pinto L; Capasso R; Di Carlo G; Izzo AA
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):333-41. PubMed ID: 12052047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between eicosanoids and cannabinoids. Are eicosanoids cannabimimetic agents?
    Burstein SH; Young JK; Wright GE
    Biochem Pharmacol; 1995 Nov; 50(11):1735-42. PubMed ID: 8615850
    [No Abstract]   [Full Text] [Related]  

  • 13. Anandamide may mediate sleep induction.
    Mechoulam R; Fride E; Hanus L; Sheskin T; Bisogno T; Di Marzo V; Bayewitch M; Vogel Z
    Nature; 1997 Sep; 389(6646):25-6. PubMed ID: 9288961
    [No Abstract]   [Full Text] [Related]  

  • 14. The neurobiology of cannabinoid transmission: from anandamide signaling to higher cerebral functions and disease.
    Navarro M; Rodríguez de Fonseca F
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):379-85. PubMed ID: 9974172
    [No Abstract]   [Full Text] [Related]  

  • 15. Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.
    Bisogno T; Berrendero F; Ambrosino G; Cebeira M; Ramos JA; Fernandez-Ruiz JJ; Di Marzo V
    Biochem Biophys Res Commun; 1999 Mar; 256(2):377-80. PubMed ID: 10079192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoid immune and vascular signaling.
    Stefano GB
    Acta Pharmacol Sin; 2000 Dec; 21(12):1071-81. PubMed ID: 11603279
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.
    Porter AC; Sauer JM; Knierman MD; Becker GW; Berna MJ; Bao J; Nomikos GG; Carter P; Bymaster FP; Leese AB; Felder CC
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1020-4. PubMed ID: 12023533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoids in the central nervous system--an overview.
    Fride E
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):221-33. PubMed ID: 12052038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endocannabinoid system as a target for therapeutic drugs.
    Piomelli D; Giuffrida A; Calignano A; Rodríguez de Fonseca F
    Trends Pharmacol Sci; 2000 Jun; 21(6):218-24. PubMed ID: 10838609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Search for endogenous ligands of the cannabinoid receptor.
    Mechoulam R; Hanus L; Martin BR
    Biochem Pharmacol; 1994 Oct; 48(8):1537-44. PubMed ID: 7980618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.